NovaBridge Biosciences (NBP)
NASDAQ: NBP · Real-Time Price · USD
0.9081
-0.1019 (-10.09%)
At close: Nov 5, 2026, 4:00 PM EST
0.9490
+0.0409 (4.50%)
After-hours: Nov 5, 2026, 7:30 PM EST
NovaBridge Biosciences Market Cap
NovaBridge Biosciences has a market cap or net worth of $105.34 million as of November 5, 2026. It is the 24,541st most valuable company in the world and the 4,009th biggest in the United States. Its market cap has decreased by 78.60% in one year.
Market Cap
105.34M
Enterprise Value
-81.05M
1-Year Change
-78.60%
Global Rank
Country Rank
#4,009 United States
Category
ChartMarket Cap Chart
Since January 17, 2020, NovaBridge Biosciences's market cap has decreased from $138.05M to $105.34M, a decrease of -23.69%. That is a compound annual growth rate of -3.90%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 5, 2026 | 105.34M | -77.04% |
| Dec 31, 2025 | 458.86M | 562.90% |
| Dec 31, 2024 | 69.22M | -56.10% |
| Dec 29, 2023 | 157.68M | -54.60% |
| Dec 30, 2022 | 347.35M | -90.48% |
| Dec 31, 2021 | 3.65B | 9.73% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jan 17, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| enGene Therapeutics | 112.92M |
| Armata Pharmaceuticals | 112.66M |
| Codexis | 112.24M |
| Minerva Neurosciences | 111.73M |
| Humacyte | 110.67M |
| Foghorn Therapeutics | 109.57M |
| Anixa Biosciences | 106.72M |
| Voyager Therapeutics | 106.29M |